Search

Allergan's Migraine-Reducing Pill Hits Study Goals, Heads to Phase 3

ALLERGAN'S MIGRAINE-REDUCING PILL HITS STUDY GOALS, HEADS TO PHASE 3

An experimental Allergan pill meant to help reduce the frequency of migraines met the main goals of a key study, bolstering its chances...

Allergan Is Recalling This Popular Drug for Containing Placebos

ALLERGAN IS RECALLING THIS POPULAR DRUG FOR CONTAINING PLACEBOS

When taking any kind of medication, there's one thing that consumers always assume is true: Each pill in their prescription is formulated...

 
 
 
Taytulla birth control pills recalled because they might not prevent pregnancy

TAYTULLA BIRTH CONTROL PILLS RECALLED BECAUSE THEY MIGHT NOT PREVENT PREGNANCY

MADISON, N.J. - Allergan is voluntarily recalling packs of its birth control pills in the U.S. because of a packaging error with placebos,...

Birth control recalled for packaging placebo pills on the wrong days

BIRTH CONTROL RECALLED FOR PACKAGING PLACEBO PILLS ON THE WRONG DAYS

Drug company Allergan has issued a voluntary recall for its birth control gel capsules, Taytulla, after realizing that four placebos...

 
 
 
Allergan is reportedly selling off two of its non-core businesses in a bid to appease frustrated investors

ALLERGAN IS REPORTEDLY SELLING OFF TWO OF ITS NON-CORE BUSINESSES IN A BID TO APPEASE FRUSTRATED INVESTORS

Allergan is planning to sell its women's health business and infectious disease business, CNBC reported Wednesday citing sources . Investors...

'Losing direction': Allergan investors are unhappy after a wild 4 hour takeover drama

'LOSING DIRECTION': ALLERGAN INVESTORS ARE UNHAPPY AFTER A WILD 4 HOUR TAKEOVER DRAMA

Allergan's stock closed down 4% on Thursday, after the pharma giant said it was "in the early stages of considering a possible offer"...

 
 
 
A bidding war is brewing over $50 billion drugmaker Shire

A BIDDING WAR IS BREWING OVER $50 BILLION DRUGMAKER SHIRE

Shire rejected Takeda's $60 billion takeover bid on Thursday, and now Allergan's reportedly entering the bidding war. The $60 billion...

Bio Roundup: Biotech IPOs, Migraine Progress, Takeda Woos Shire & More

BIO ROUNDUP: BIOTECH IPOS, MIGRAINE PROGRESS, TAKEDA WOOS SHIRE & MORE

If the recent IPO activity seems to be on overdrive, it's not your imagination. The number of companies filing to go public in the...

 
 
 
Out With the Old and in With the NEW!

OUT WITH THE OLD AND IN WITH THE NEW!

Here at Spring Ridge Plastic Surgery, we are excited about the new generation of Gummy Bear breast implants by Natrelle®. Allergan,...

ALLERGAN TO PRESENT AT THE 36TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

DUBLIN, Dec. 26, 2017 /PRNewswire/ - Allergan plc , a leading global biopharmaceutical company, today announced that Chairman and CEO...

 
 
 
Xconomy Newcomer Award Winner Amy Schulman on Boston Biotech Life

XCONOMY NEWCOMER AWARD WINNER AMY SCHULMAN ON BOSTON BIOTECH LIFE

Amy Schulman is relatively new not just to Boston, but also to biotech. Before she moved to Boston in 2014 to join Polaris Partners,...

 
 
 
Botox maker Allergan raises the lower end of its earnings forecast

BOTOX MAKER ALLERGAN RAISES THE LOWER END OF ITS EARNINGS FORECAST

Reuters/ Jim Young Allergan missed on revenue, but beat on earnings. The company raised the lower end of its adjusted earnings guidance....

 
 
 
 
 
 
The maker of Botox has turned to the oldest trick in the book to save its cratering stock

THE MAKER OF BOTOX HAS TURNED TO THE OLDEST TRICK IN THE BOOK TO SAVE ITS CRATERING STOCK

To combat recent stock weakness, Botox-maker Allergan is resorting to the oldest trick in the book: share buybacks . On Monday, it...

Seeking to Cash in For Investors Again, Rhythm Pharma Files For IPO

SEEKING TO CASH IN FOR INVESTORS AGAIN, RHYTHM PHARMA FILES FOR IPO

Most biotechs pursue either a sale or an IPO to reward their investors. Rhythm Pharmaceuticals is now trying to accomplish both. A...

 
 
 
Austin's Apollo Endosurgery Responds to FDA Note After Patient Deaths

AUSTIN'S APOLLO ENDOSURGERY RESPONDS TO FDA NOTE AFTER PATIENT DEATHS

Austin -Two years after gaining FDA approval to market a minimally invasive gastrointestinal balloon to combat obesity, Apollo Endosurgery...